Global NGS-based RNA-sequencing Market Size study, By Product & Service (Sample Preparation Products, Sequencing Platforms & Consumables, Sequencing Services, Data Analysis, Storage, & Management), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics), By End User (Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), and Regional Forecasts 2022-2028
- BIZ4950843
- 200 Pages
- March 2022
- Diagnostic and Biotech
RNA sequencing (RNA-Seq) is a high throughput next-generation sequencing method that is used to identify and quantify the RNA present in a biological sample in the present time. The NGS presents a wide range and compassion for improved detection of varyingly expressed genes with quantifiable data. This method is highly used in both non-conventional and conventional applications for obtaining advanced and inclusive insights at a genomic level. The rising number of RNA-Seq grants, the high characteristics of RNA-Seq over conventional technologies, coupled with the growing demand for precision medicine are the primary factors that may accelerate the market growth across the globe. In addition, increasing research and development activities including RNA-seq, coupled with the rising number of strategic actions such as mergers, acquisitions, strengthening product portfolio, etc. by the leading market players are the further factors that may propel the market demand in the near future. For instance, in November 2018, Illumina acquired Pacific Biosciences- a leading provider of sequencing systems with the aim of expanding the company’s sequencing product portfolio. Also, in May 2019, GenomiQa and BGI Group entered into the services agreement for overall-genome sequencing on BGI’s DNBseqTM sequencing technology platform for using BGI’s ISO15189 accredited laboratory sequencing facilities by the genomiQa. However, the lack of skilled professionals and standardization concerns of RNA-seq in diagnostic testing impedes the growth of the market over the forecast period of 2022-2028. Also, increasing applications of RNA-Seq in research and rising investment in R&D are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global NGS-based RNA-sequencing market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to technological developments in RNA-Seq products and the huge presence of major market players such as Thermo Fisher, Illumina, and Agilent Technologies. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing incidences of target diseases, as well as government support by providing funds for genomics research, would create lucrative growth prospects for the NGS-based RNA-sequencing market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific Inc.
Illumina Inc.
Pacific Biosciences of California, Inc.
F. Hoffman-La Roche Ltd
Agilent Technologies Inc.
BGI Group
Oxford Nanopre Technologies Ltd.
Eurofins Scientific Company
Qiagen Company
Perkinelmer Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
Sample Preparation Products
Sequencing Platforms & Consumables
Sequencing Services
Data Analysis, Storage, & Management
By Technology:
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application:
Expression Profiling Analysis
Small RNA Sequencing
De Novo Transcriptome Assembly
Variant Calling & Transcriptome Epigenetics
By End User:
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global NGS-based RNA-sequencing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global NGS-based RNA-sequencing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global NGS-based RNA-sequencing Market, by Product & Service, 2020-2028 (USD Billion)
1.2.3. Global NGS-based RNA-sequencing Market, by Technology, 2020-2028 (USD Billion)
1.2.4. Global NGS-based RNA-sequencing Market, by Application, 2020-2028 (USD Billion)
1.2.5. Global NGS-based RNA-sequencing Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global NGS-based RNA-sequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global NGS-based RNA-sequencing Market Dynamics
3.1. NGS-based RNA-sequencing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing number of RNA-Seq grants
3.1.1.2. Increasing development in precision medicine
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.2.2. Standardization concerns of RNA-seq in diagnostic testing
3.1.3. Market Opportunities
3.1.3.1. Increasing applications of RNA-Seq in research
3.1.3.2. Rising investment in R&D
Chapter 4. Global NGS-based RNA-sequencing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global NGS-based RNA-sequencing Market, by Product & Service
6.1. Market Snapshot
6.2. Global NGS-based RNA-sequencing Market by Product & Service, Performance - Potential Analysis
6.3. Global NGS-based RNA-sequencing Market Estimates & Forecasts by Product & Service 2019-2028 (USD Billion)
6.4. NGS-based RNA-sequencing Market, Sub Segment Analysis
6.4.1. Sample Preparation Products
6.4.2. Sequencing Platforms & Consumables
6.4.3. Sequencing Services
6.4.4. Data Analysis, Storage, & Management
Chapter 7. Global NGS-based RNA-sequencing Market, by Technology
7.1. Market Snapshot
7.2. Global NGS-based RNA-sequencing Market by Technology, Performance - Potential Analysis
7.3. Global NGS-based RNA-sequencing Market Estimates & Forecasts by Technology 2019-2028 (USD Billion)
7.4. NGS-based RNA-sequencing Market, Sub Segment Analysis
7.4.1. Sequencing by Synthesis
7.4.2. Ion Semiconductor Sequencing
7.4.3. Single-molecule Real-time Sequencing
7.4.4. Nanopore Sequencing
Chapter 8. Global NGS-based RNA-sequencing Market, by Application
8.1. Market Snapshot
8.2. Global NGS-based RNA-sequencing Market by Application, Performance - Potential Analysis
8.3. Global NGS-based RNA-sequencing Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
8.4. NGS-based RNA-sequencing Market, Sub Segment Analysis
8.4.1. Expression Profiling Analysis
8.4.2. Small RNA Sequencing
8.4.3. De Novo Transcriptome Assembly
8.4.4. Variant Calling & Transcriptome Epigenetics
Chapter 9. Global NGS-based RNA-sequencing Market, by End User
9.1. Market Snapshot
9.2. Global NGS-based RNA-sequencing Market by End User, Performance - Potential Analysis
9.3. Global NGS-based RNA-sequencing Market Estimates & Forecasts by End User 2019-2028 (USD Billion)
9.4. NGS-based RNA-sequencing Market, Sub Segment Analysis
9.4.1. Research & Academia
9.4.2. Hospitals & Clinics
9.4.3. Pharmaceutical & Biotechnology Companies
9.4.4. Other End Users
Chapter 10. Global NGS-based RNA-sequencing Market, Regional Analysis
10.1. NGS-based RNA-sequencing Market, Regional Market Snapshot
10.2. North America NGS-based RNA-sequencing Market
10.2.1. U.S. NGS-based RNA-sequencing Market
10.2.1.1. Product & Service estimates & forecasts, 2019-2028
10.2.1.2. Technology estimates & forecasts, 2019-2028
10.2.1.3. Application estimates & forecasts, 2019-2028
10.2.1.4. End User estimates & forecasts, 2019-2028
10.2.2. Canada NGS-based RNA-sequencing Market
10.3. Europe NGS-based RNA-sequencing Market Snapshot
10.3.1. U.K. NGS-based RNA-sequencing Market
10.3.2. Germany NGS-based RNA-sequencing Market
10.3.3. France NGS-based RNA-sequencing Market
10.3.4. Spain NGS-based RNA-sequencing Market
10.3.5. Italy NGS-based RNA-sequencing Market
10.3.6. Rest of Europe NGS-based RNA-sequencing Market
10.4. Asia-Pacific NGS-based RNA-sequencing Market Snapshot
10.4.1. China NGS-based RNA-sequencing Market
10.4.2. India NGS-based RNA-sequencing Market
10.4.3. Japan NGS-based RNA-sequencing Market
10.4.4. Australia NGS-based RNA-sequencing Market
10.4.5. South Korea NGS-based RNA-sequencing Market
10.4.6. Rest of Asia Pacific NGS-based RNA-sequencing Market
10.5. Latin America NGS-based RNA-sequencing Market Snapshot
10.5.1. Brazil NGS-based RNA-sequencing Market
10.5.2. Mexico NGS-based RNA-sequencing Market
10.6. Rest of The World NGS-based RNA-sequencing Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Illumina Inc.
11.2.3. Pacific Biosciences of California, Inc.
11.2.4. F. Hoffman-La Roche Ltd
11.2.5. Agilent Technologies Inc.
11.2.6. BGI’Group
11.2.7. Oxford Nanopre Technologies Ltd.
11.2.8. Eurofins Scientific Company
11.2.9. Qiagen Company
11.2.10. Perkinelmer Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global NGS-based RNA-sequencing Market, report scope
TABLE 2. Global NGS-based RNA-sequencing Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global NGS-based RNA-sequencing Market estimates & forecasts by Product & Service 2019-2028 (USD Billion)
TABLE 4. Global NGS-based RNA-sequencing Market estimates & forecasts by Technology 2019-2028 (USD Billion)
TABLE 5. Global NGS-based RNA-sequencing Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 6. Global NGS-based RNA-sequencing Market estimates & forecasts by End User 2019-2028 (USD Billion)
TABLE 7. Global NGS-based RNA-sequencing Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global NGS-based RNA-sequencing Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global NGS-based RNA-sequencing Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global NGS-based RNA-sequencing Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global NGS-based RNA-sequencing Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global NGS-based RNA-sequencing Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global NGS-based RNA-sequencing Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global NGS-based RNA-sequencing Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global NGS-based RNA-sequencing Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global NGS-based RNA-sequencing Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. U.S. NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. Canada NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. Canada NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. UK NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. UK NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. Germany NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. Germany NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. RoE NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. RoE NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. China NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. China NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. India NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. India NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. Japan NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. Japan NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. RoAPAC NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. RoAPAC NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. Brazil NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Brazil NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Mexico NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Mexico NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. RoLA NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. RoLA NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row NGS-based RNA-sequencing Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. Row NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. Row NGS-based RNA-sequencing Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global NGS-based RNA-sequencing Market
TABLE 57. List of primary sources, used in the study of global NGS-based RNA-sequencing Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
